Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Francisco La Rosa

Concepts (412)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
21
2022
1049
2.270
Why?
Urinary Bladder Neoplasms
6
2024
261
1.460
Why?
Prostate
9
2022
174
1.310
Why?
Testicular Neoplasms
2
2026
114
1.030
Why?
Testicular Diseases
1
2026
7
0.980
Why?
Histiocytosis, Sinus
1
2026
8
0.970
Why?
Lymphoma, B-Cell, Marginal Zone
1
2026
17
0.970
Why?
Kidney Neoplasms
9
2014
403
0.930
Why?
Prostatectomy
9
2022
102
0.660
Why?
Carcinoma, Papillary
3
2015
72
0.590
Why?
Adenocarcinoma
4
2014
883
0.570
Why?
Solitary Fibrous Tumors
1
2017
4
0.530
Why?
Neoplasms, Multiple Primary
2
2015
58
0.530
Why?
Spectrum Analysis
1
2016
91
0.490
Why?
Carcinoma, Renal Cell
3
2013
220
0.480
Why?
Biopsy
8
2019
1093
0.440
Why?
Thyroid Gland
8
1992
91
0.430
Why?
Carcinoma, Transitional Cell
1
2014
80
0.420
Why?
Neoplasms, Complex and Mixed
1
2013
8
0.420
Why?
Lung Neoplasms
3
2026
2530
0.420
Why?
Carcinoma, Medullary
1
2013
17
0.410
Why?
Carcinoma, Squamous Cell
2
2015
646
0.390
Why?
Neoplasm Invasiveness
5
2024
501
0.360
Why?
Biopsy, Needle
5
2016
192
0.360
Why?
Cystectomy
2
2024
41
0.350
Why?
Diagnosis, Differential
6
2026
1492
0.340
Why?
Neoplasm Grading
6
2022
306
0.340
Why?
Urothelium
3
2015
38
0.330
Why?
Lymph Node Excision
2
2024
168
0.330
Why?
Neoplasms, Germ Cell and Embryonal
2
2021
78
0.320
Why?
Male
49
2026
68035
0.320
Why?
Cyclic AMP
7
2000
219
0.310
Why?
Mediastinal Diseases
1
2007
11
0.280
Why?
Carcinoid Tumor
1
2007
23
0.270
Why?
Neuroblastoma
8
2010
160
0.260
Why?
Aged
17
2024
24134
0.260
Why?
Parotid Gland
6
1997
22
0.250
Why?
Ubiquitins
4
2000
37
0.240
Why?
Orchiectomy
1
2026
75
0.240
Why?
Sarcoidosis
1
2007
162
0.230
Why?
Cell Division
6
2000
790
0.230
Why?
Positron Emission Tomography Computed Tomography
1
2026
104
0.230
Why?
Humans
52
2026
138201
0.230
Why?
Sphingosine
1
2025
45
0.220
Why?
Neoplasm Staging
4
2024
1375
0.220
Why?
Lysophospholipids
1
2025
80
0.220
Why?
Mitochondria, Heart
1
2025
100
0.220
Why?
Myocardial Reperfusion Injury
1
2025
136
0.210
Why?
Perfusion
1
2025
224
0.210
Why?
Lymphatic Diseases
2
2009
22
0.210
Why?
Finasteride
3
2008
36
0.210
Why?
Myocardial Contraction
1
2025
302
0.210
Why?
Image-Guided Biopsy
2
2012
37
0.200
Why?
Cell Transplantation
3
1997
38
0.190
Why?
Major Histocompatibility Complex
5
1990
230
0.190
Why?
Urinary Bladder
2
2014
186
0.180
Why?
Prostate-Specific Antigen
7
2020
166
0.180
Why?
Antigens, Polyomavirus Transforming
3
1998
18
0.180
Why?
Retroperitoneal Neoplasms
1
2021
21
0.180
Why?
Seminoma
1
2021
20
0.170
Why?
Immunohistochemistry
2
2017
1727
0.170
Why?
Graft Rejection
8
1990
577
0.170
Why?
Biomarkers, Tumor
3
2020
1237
0.170
Why?
Middle Aged
18
2024
33711
0.160
Why?
Teratoma
1
2021
118
0.160
Why?
Imaging, Three-Dimensional
2
2015
566
0.160
Why?
H-2 Antigens
4
1992
115
0.160
Why?
Pyrroles
2
2013
211
0.160
Why?
Support Vector Machine
2
2016
38
0.150
Why?
Islets of Langerhans Transplantation
5
1992
65
0.150
Why?
Liver Cirrhosis, Experimental
1
2019
11
0.150
Why?
Perilipin-2
1
2019
41
0.150
Why?
Heart Transplantation
1
2025
695
0.150
Why?
Chemotherapy, Adjuvant
2
2024
377
0.140
Why?
Cell Transformation, Viral
2
1997
25
0.140
Why?
Nephrectomy
3
2014
159
0.140
Why?
Histocompatibility Antigens
4
1988
106
0.140
Why?
Amyloid beta-Peptides
5
2000
219
0.140
Why?
Antineoplastic Agents
5
2013
2158
0.140
Why?
Hepatocytes
1
2019
216
0.140
Why?
Radiotherapy, Adjuvant
1
2018
215
0.140
Why?
Tumor Burden
2
2017
307
0.140
Why?
Indoles
2
2013
411
0.140
Why?
Factor X Deficiency
1
1997
4
0.130
Why?
Rodenticides
1
1997
5
0.130
Why?
Hydatidiform Mole
1
1997
4
0.130
Why?
4-Hydroxycoumarins
1
1997
4
0.130
Why?
Colonic Pouches
1
2017
15
0.130
Why?
Pregnancy, High-Risk
1
1997
14
0.130
Why?
Graft Survival
5
1996
527
0.130
Why?
Arrhythmias, Cardiac
1
2019
326
0.130
Why?
Prognosis
5
2019
4017
0.130
Why?
Sensitivity and Specificity
3
2016
1951
0.130
Why?
Maternal Age
1
1997
127
0.130
Why?
Genital Neoplasms, Male
1
2016
5
0.130
Why?
Cardiomyopathy, Dilated
1
2019
330
0.130
Why?
Granular Cell Tumor
1
2016
9
0.130
Why?
HIV Seropositivity
1
1997
127
0.120
Why?
alpha-Amylases
4
1995
16
0.120
Why?
Scrotum
1
2016
25
0.120
Why?
Uterine Neoplasms
1
1997
115
0.120
Why?
Non-alcoholic Fatty Liver Disease
1
2019
279
0.120
Why?
Mice
24
2025
17761
0.120
Why?
Blood Coagulation
1
1997
255
0.110
Why?
Cystotomy
1
2014
4
0.110
Why?
Prostatitis
1
2014
18
0.110
Why?
Growth Differentiation Factor 15
1
2014
40
0.110
Why?
Muscle, Smooth
1
2015
151
0.110
Why?
Animals
34
2025
37129
0.110
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2014
59
0.110
Why?
Adult
15
2024
38190
0.110
Why?
Adrenergic beta-Agonists
2
1995
97
0.110
Why?
Enzyme Inhibitors
2
2007
849
0.100
Why?
Optics and Photonics
1
2014
42
0.100
Why?
Risk Assessment
2
2020
3452
0.100
Why?
Marijuana Smoking
1
1997
254
0.100
Why?
Spectrometry, Fluorescence
1
2014
170
0.100
Why?
Neurons
6
1999
1594
0.100
Why?
Tumor Cells, Cultured
8
2000
947
0.100
Why?
Abortion, Habitual
1
1992
5
0.100
Why?
Biopsy, Large-Core Needle
1
2012
14
0.100
Why?
Treatment Outcome
4
2017
10914
0.100
Why?
Antibodies, Anticardiolipin
1
1992
11
0.100
Why?
Bone Neoplasms
1
2015
249
0.100
Why?
Tomography, X-Ray Computed
4
2017
2694
0.100
Why?
Culture Media
4
1994
163
0.100
Why?
Prostatic Intraepithelial Neoplasia
2
2014
11
0.100
Why?
Niacinamide
1
2013
82
0.100
Why?
Phenylurea Compounds
1
2013
97
0.090
Why?
Proto-Oncogene Proteins p21(ras)
1
2013
263
0.090
Why?
Carcinoma, Basal Cell
1
2013
73
0.090
Why?
Immune Tolerance
2
1992
366
0.090
Why?
Organ Culture Techniques
2
1992
156
0.090
Why?
Angiomyolipoma
1
2011
23
0.090
Why?
Triiodothyronine
1
2011
42
0.090
Why?
Vascular Neoplasms
1
2011
17
0.090
Why?
Immunoglobulin A
1
1992
214
0.090
Why?
Immunoglobulin M
1
1992
290
0.090
Why?
Sarcoma
1
2013
189
0.090
Why?
Thyroxine
1
2011
63
0.090
Why?
HIV-1
1
1997
887
0.090
Why?
NF-kappa B
1
2014
679
0.080
Why?
Hypothyroidism
1
2011
73
0.080
Why?
Thrombocytopenia
1
1992
201
0.080
Why?
Mice, Inbred Strains
6
1992
409
0.080
Why?
Antigens
1
1992
356
0.080
Why?
Lupus Erythematosus, Systemic
1
1992
239
0.080
Why?
Recombinant Fusion Proteins
1
2012
662
0.080
Why?
Tumor Suppressor Protein p53
1
2013
525
0.080
Why?
Rats
12
2000
5565
0.080
Why?
Cystitis
1
2009
23
0.080
Why?
Organ Size
3
2019
474
0.070
Why?
Thrombosis
1
1992
374
0.070
Why?
Neurotoxins
2
1998
28
0.070
Why?
Cyclosporine
2
2000
268
0.070
Why?
Histocompatibility Antigens Class II
1
1990
365
0.070
Why?
Pneumatosis Cystoides Intestinalis
1
2008
21
0.070
Why?
Referral and Consultation
2
2011
796
0.070
Why?
Female
17
2024
73713
0.070
Why?
Immunoglobulin G
1
1992
903
0.070
Why?
Intestinal Perforation
1
2008
46
0.070
Why?
Transplantation Immunology
1
1988
32
0.070
Why?
Graft Enhancement, Immunologic
1
1987
1
0.070
Why?
Chemoprevention
1
2008
95
0.070
Why?
Radionuclide Imaging
1
2007
118
0.070
Why?
Aged, 80 and over
4
2024
7683
0.070
Why?
Magnetic Resonance Imaging
3
2015
3636
0.070
Why?
Lymphatic Metastasis
2
2024
325
0.070
Why?
Minor Histocompatibility Loci
1
1987
4
0.070
Why?
Fluorescent Antibody Technique
4
2013
384
0.070
Why?
Anticarcinogenic Agents
1
2007
77
0.060
Why?
Protein Kinase Inhibitors
1
2013
914
0.060
Why?
Kidney Diseases, Cystic
1
2006
25
0.060
Why?
Staining and Labeling
3
2013
155
0.060
Why?
Cohort Studies
2
2020
5717
0.060
Why?
Rats, Sprague-Dawley
6
1998
2472
0.060
Why?
Mice, Inbred C57BL
5
2025
5770
0.060
Why?
Obesity
1
2019
2990
0.060
Why?
Amyloid beta-Protein Precursor
3
2000
66
0.060
Why?
Skin Neoplasms
1
2013
853
0.060
Why?
Transplantation, Homologous
5
1992
414
0.060
Why?
Syndrome
2
2021
377
0.060
Why?
Cell Line, Transformed
4
1998
145
0.060
Why?
Cell Differentiation
5
2000
1999
0.060
Why?
Breast Neoplasms
1
1997
2294
0.060
Why?
Dopamine
2
1998
308
0.050
Why?
Culture Techniques
3
1990
73
0.050
Why?
Alprostadil
3
1999
32
0.050
Why?
Observer Variation
2
2015
349
0.050
Why?
Disease-Free Survival
1
2024
704
0.050
Why?
Liver
1
2011
1872
0.050
Why?
Image Interpretation, Computer-Assisted
2
2015
268
0.050
Why?
Kaplan-Meier Estimate
1
2024
902
0.050
Why?
Neoadjuvant Therapy
1
2024
409
0.050
Why?
Reproducibility of Results
3
2014
3300
0.050
Why?
CD4 Antigens
2
1992
141
0.040
Why?
Remission, Spontaneous
1
2021
40
0.040
Why?
Disease Models, Animal
3
2025
4308
0.040
Why?
Neoplasm, Residual
1
2021
133
0.040
Why?
T-Lymphocytes, Cytotoxic
3
1992
174
0.040
Why?
Lung Diseases, Interstitial
1
2006
641
0.040
Why?
Aluminum
1
2000
43
0.040
Why?
Peptidylprolyl Isomerase
1
1999
9
0.040
Why?
Perineum
1
2019
31
0.040
Why?
RNA, Messenger
6
1999
2808
0.040
Why?
Adenylyl Cyclases
2
1996
63
0.040
Why?
Fetal Tissue Transplantation
1
1998
36
0.040
Why?
Prostaglandins
1
1998
101
0.040
Why?
Cells, Cultured
7
1998
4159
0.040
Why?
Retrospective Studies
2
2015
15842
0.040
Why?
Prostaglandins A
1
1998
9
0.040
Why?
Radiometry
1
2018
50
0.040
Why?
Growth Inhibitors
1
1998
44
0.040
Why?
CD8 Antigens
3
1992
75
0.030
Why?
Radiotherapy Dosage
1
2018
280
0.030
Why?
Genes, p53
1
1997
70
0.030
Why?
Lung Diseases, Obstructive
1
1997
47
0.030
Why?
Diet, High-Fat
1
2019
248
0.030
Why?
Salvage Therapy
1
2018
152
0.030
Why?
Radiotherapy, Intensity-Modulated
1
2018
137
0.030
Why?
Fluorescent Antibody Technique, Indirect
1
1997
47
0.030
Why?
Vitamin K 1
1
1997
3
0.030
Why?
Chorionic Gonadotropin, beta Subunit, Human
1
1997
16
0.030
Why?
Prothrombin Time
1
1997
35
0.030
Why?
Protein Processing, Post-Translational
1
1999
463
0.030
Why?
Blood Coagulation Factors
1
1997
54
0.030
Why?
Point Mutation
1
1997
238
0.030
Why?
Isoproterenol
2
1994
101
0.030
Why?
Tyrosine 3-Monooxygenase
1
1996
72
0.030
Why?
Mesencephalon
1
1996
66
0.030
Why?
Brain
2
1998
2748
0.030
Why?
Alzheimer Disease
2
2000
566
0.030
Why?
Islets of Langerhans
3
1992
793
0.030
Why?
Hysterectomy
1
1997
134
0.030
Why?
Bronchi
1
1997
266
0.030
Why?
Mouth Mucosa
1
1996
91
0.030
Why?
Glioma
1
2000
402
0.030
Why?
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
3
2000
3
0.030
Why?
Corpus Striatum
1
1997
175
0.030
Why?
Lymphocytes
2
1988
399
0.030
Why?
Membrane Transport Proteins
1
1996
151
0.030
Why?
Immunosuppressive Agents
1
2000
864
0.030
Why?
Prostatic Hyperplasia
1
2015
41
0.030
Why?
Adenoma, Pleomorphic
1
1994
10
0.030
Why?
Parotid Neoplasms
1
1994
15
0.030
Why?
Mice, Inbred BALB C
3
1989
1260
0.030
Why?
Patient Selection
1
2018
692
0.030
Why?
Adipose Tissue
1
2019
643
0.030
Why?
Genetic Variation
1
2019
1002
0.030
Why?
Wavelet Analysis
1
2014
7
0.030
Why?
Atrophy
1
2014
189
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
2
1991
97
0.030
Why?
Least-Squares Analysis
1
2014
78
0.030
Why?
Terbutaline
1
1993
8
0.030
Why?
Dobutamine
1
1993
26
0.030
Why?
beta-Galactosidase
1
2013
79
0.030
Why?
Breeding
1
2013
65
0.030
Why?
Needles
1
2014
61
0.030
Why?
Autopsy
1
2013
94
0.030
Why?
Glucose
1
2019
1032
0.030
Why?
Membrane Glycoproteins
1
1996
500
0.030
Why?
Phenotype
2
2019
3153
0.030
Why?
T-Lymphocyte Subsets
2
1992
417
0.020
Why?
Hyperplasia
1
2013
176
0.020
Why?
Keratins
1
2013
171
0.020
Why?
Tumor Stem Cell Assay
1
2012
34
0.020
Why?
Organ Specificity
1
2013
308
0.020
Why?
Kallikreins
1
2012
28
0.020
Why?
Adenoviridae
1
2013
200
0.020
Why?
Integrases
1
2013
120
0.020
Why?
Lymphocyte Activation
3
1992
1145
0.020
Why?
Diffusion Magnetic Resonance Imaging
1
2014
154
0.020
Why?
Health Surveys
1
2014
521
0.020
Why?
Parkinson Disease
1
1998
546
0.020
Why?
Nerve Tissue Proteins
1
1996
597
0.020
Why?
RNA, Untranslated
1
2013
124
0.020
Why?
Equipment Design
1
2014
512
0.020
Why?
Minor Histocompatibility Antigens
1
1992
47
0.020
Why?
Pregnancy
2
1997
6792
0.020
Why?
Time Factors
2
1996
6848
0.020
Why?
T-Lymphocytes
2
1991
1982
0.020
Why?
Antigens, CD
1
2014
530
0.020
Why?
Clone Cells
3
1996
264
0.020
Why?
Cell Line
2
1994
2865
0.020
Why?
Actins
1
1993
419
0.020
Why?
Macrophages
1
2019
1544
0.020
Why?
Risk Factors
2
2019
10366
0.020
Why?
Insulin Resistance
1
2019
1225
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
1992
851
0.020
Why?
Lymphokines
1
1990
133
0.020
Why?
Smoking
1
1997
1601
0.020
Why?
Laparoscopy
1
2014
446
0.020
Why?
Xenograft Model Antitumor Assays
1
2012
865
0.020
Why?
Phosphodiesterase Inhibitors
2
2000
76
0.020
Why?
Inflammation
2
1998
2843
0.020
Why?
Proteins
1
1995
1013
0.020
Why?
ErbB Receptors
1
2012
611
0.020
Why?
Diabetes Mellitus, Experimental
1
1991
197
0.020
Why?
Nephrolithiasis
1
2009
10
0.020
Why?
Recurrence
1
1992
1102
0.020
Why?
Metaplasia
1
2009
58
0.020
Why?
Computer Simulation
1
2013
989
0.020
Why?
Interferon-gamma
2
1990
788
0.020
Why?
Neoplasm Metastasis
1
2011
673
0.020
Why?
Hematopoietic Stem Cells
1
1992
410
0.020
Why?
Interferons
1
1990
202
0.020
Why?
Odds Ratio
1
2011
1080
0.020
Why?
Genotype
1
2013
1873
0.020
Why?
Dose-Response Relationship, Drug
1
2012
2027
0.020
Why?
Mice, Transgenic
1
2013
2166
0.020
Why?
Positron-Emission Tomography
1
2009
302
0.020
Why?
Cross-Sectional Studies
1
2019
5518
0.020
Why?
Placebos
1
2008
197
0.020
Why?
Cisplatin
1
2009
327
0.020
Why?
Immunologic Memory
1
1990
358
0.020
Why?
Multivariate Analysis
1
2011
1495
0.020
Why?
Bucladesine
2
1998
24
0.020
Why?
Histocompatibility Antigens Class I
1
1989
203
0.020
Why?
Adolescent
2
2016
21503
0.020
Why?
Predictive Value of Tests
1
2012
2037
0.020
Why?
Medical History Taking
1
2007
117
0.020
Why?
Bias
1
2007
224
0.020
Why?
Kidney Transplantation
1
1992
701
0.020
Why?
Hydrogen-Ion Concentration
1
1987
556
0.020
Why?
Endocrine Glands
1
1986
16
0.020
Why?
Pedigree
1
2007
511
0.020
Why?
Radiography
1
2008
845
0.010
Why?
Culture Media, Serum-Free
2
1998
46
0.010
Why?
Physicians
1
2014
926
0.010
Why?
Hypersensitivity, Delayed
1
1985
30
0.010
Why?
Cell Proliferation
1
2012
2470
0.010
Why?
Cell Survival
1
1988
1128
0.010
Why?
Cell Line, Tumor
1
2012
3403
0.010
Why?
Antigen-Presenting Cells
1
1985
157
0.010
Why?
Case-Control Studies
1
2011
3574
0.010
Why?
Early Detection of Cancer
1
2008
432
0.010
Why?
Testosterone
1
2007
401
0.010
Why?
Neoplasm Recurrence, Local
1
2009
1065
0.010
Why?
Young Adult
1
2020
13298
0.010
Why?
Cross Reactions
1
1983
130
0.010
Why?
Mice, Inbred C3H
1
1983
269
0.010
Why?
Colorado
1
2012
4526
0.010
Why?
Logistic Models
1
2007
2083
0.010
Why?
Lymphocyte Depletion
2
1992
134
0.010
Why?
Transfection
2
1994
941
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1755
0.010
Why?
Incidence
1
2007
2820
0.010
Why?
Prospective Studies
1
2012
7611
0.010
Why?
Alum Compounds
1
2000
27
0.010
Why?
Neurites
1
2000
47
0.010
Why?
Oxygen Consumption
1
1983
707
0.010
Why?
Carotenoids
1
1999
43
0.010
Why?
Severity of Illness Index
1
2007
2857
0.010
Why?
Follow-Up Studies
1
2008
5160
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.010
Why?
Polymorphism, Restriction Fragment Length
1
1997
66
0.010
Why?
Codon
1
1997
90
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
1999
980
0.010
Why?
Simian virus 40
1
1996
25
0.010
Why?
Transplantation, Heterotopic
1
1996
18
0.010
Why?
Butyric Acid
1
1996
7
0.010
Why?
Epithelium
1
1997
316
0.010
Why?
Xerostomia
1
1996
16
0.010
Why?
Oxidopamine
1
1996
16
0.010
Why?
3,4-Dihydroxyphenylacetic Acid
1
1996
19
0.010
Why?
Protein Kinase C beta
1
1996
20
0.010
Why?
Carbocyanines
1
1996
32
0.010
Why?
Phosphopyruvate Hydratase
1
1996
26
0.010
Why?
Exons
1
1997
355
0.010
Why?
Receptors, Adrenergic, alpha
1
1996
21
0.010
Why?
Stereotyped Behavior
1
1996
21
0.010
Why?
Nestin
1
1996
20
0.010
Why?
Intermediate Filament Proteins
1
1996
58
0.010
Why?
Proline-Rich Protein Domains
1
1995
2
0.010
Why?
Diabetes Mellitus, Type 1
1
1992
3628
0.010
Why?
Protein Kinase C-delta
1
1996
48
0.010
Why?
Muscarinic Agonists
1
1995
15
0.010
Why?
Salivary Proteins and Peptides
1
1995
14
0.010
Why?
Adrenergic alpha-Agonists
1
1995
28
0.010
Why?
Dopamine Plasma Membrane Transport Proteins
1
1996
59
0.010
Why?
Peptide Fragments
1
2000
691
0.010
Why?
Cells, Immobilized
1
1995
21
0.010
Why?
Receptors, Adrenergic, beta
1
1996
69
0.010
Why?
Butyrates
1
1996
60
0.010
Why?
Methamphetamine
1
1996
67
0.010
Why?
Isoenzymes
1
1996
304
0.010
Why?
Immunoblotting
1
1995
306
0.010
Why?
Protein Kinase C
1
1996
254
0.010
Why?
Antibodies, Monoclonal
2
1992
1437
0.010
Why?
Fluorescent Dyes
1
1996
318
0.010
Why?
Neoplasm Transplantation
1
1994
250
0.010
Why?
Crosses, Genetic
1
1992
135
0.010
Why?
Kinetics
1
1996
1641
0.010
Why?
Mice, Nude
1
1994
688
0.010
Why?
Feasibility Studies
1
1996
969
0.010
Why?
Carrier Proteins
1
1996
737
0.010
Why?
Blotting, Western
1
1994
1224
0.010
Why?
Plasmids
1
1992
359
0.010
Why?
Models, Biological
2
1991
1785
0.010
Why?
Mice, Inbred NOD
1
1992
596
0.010
Why?
Spleen
1
1992
521
0.010
Why?
Mice, Mutant Strains
1
1991
306
0.010
Why?
Interleukin-3
1
1990
25
0.010
Why?
United States
1
2007
14983
0.010
Why?
Lymph Nodes
1
1992
495
0.010
Why?
Peptides
1
1995
982
0.000
Why?
Flow Cytometry
1
1992
1197
0.000
Why?
Interleukin-2
1
1990
451
0.000
Why?
Epithelial Cells
1
1992
1101
0.000
Why?
Tumor Necrosis Factor-alpha
1
1990
1245
0.000
Why?
CD4-Positive T-Lymphocytes
1
1990
1101
0.000
Why?
Blood Glucose
1
1992
2190
0.000
Why?
La Rosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)